The company was founded in 2017 as a project of MSL Industries GmbH and was spun off as a separate company on 18.07.2018 as Cannerald GmbH based in Pfäffikon, Switzerland. The company‘s goal is to educate all generations that cannabis is not seen as an entry-level drug, but to point out the benefits of the health and healing of cancer patients, to advance research in these areas and to provide people with their own products. At the same time, the integration of a token also makes it possible for people to participate in the planting and sale of cannabis, even though the cultivation and consumption of these plants is unfortunately still prohibited in some countries. Thus, the balancing act between technology, pharmaceuticals, cultivation and consumption is ideal and to date unique in the industry.